Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Fellowship

University of Toronto

$135,000.00

Humoral and cellular immunity to measles and varicella in immunocompromised children

EF 2023-24

Résumé
Measles and chickenpox infections in immunocompromised children cause severe disease and death, and trigger outbreaks in schools and hospitals, putting all children at risk. Approximately 3% of Canadian children are immunocompromised, and this population is expected to grow with increasing use of powerful new medications that effectively treat cancer and autoimmune diseases but also cause profound immune suppression. Children with weakened immune systems may not be sufficiently protected by routine childhood vaccines. Currently, little is known about the factors that affect vaccine-induced antibody levels or how immune cells contribute to protection in this context, resulting in insufficient data to guide clinical practice and infection control measures. In this project, I will evaluate how the measles and chickenpox vaccines protect at-risk children who have weakened immune systems. Using blood samples that have already been collected from children with leukemia, children with arthritis, and healthy controls, I will measure the quantity and quality of antibodies that prevent measles and chickenpox infections. I will also measure how well T cells that target measles and chickenpox reduce the severity of disease and resolve infections, using innovative techniques to acquire in-depth data from low-volume pediatric blood samples. I will compare immune parameters between immunocompromised children and healthy children and use paired samples collected from children before and during treatment to measure changes over time. Next, I will identify characteristics of children who are at greatest risk of not being protected from measles and varicella. Finally, using paired samples collected during and after treatment, I will evaluate the potential for recovery of the immune response. Together, this project will generate recommendations for clinical practice and vaccination policies for at-risk children with weakened immune systems.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
492460
Name
Shapiro Janna
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Human Development, Child and Youth Health
Theme2
Biomedical
Prcname2
Fellowships - Post-PhD
Projecttitle
Humoral and cellular immunity to measles and varicella in immunocompromised children
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Acute Lymphoblastic; Antibodies; Autoimmunity; Immunocompromised; Juvenile Idiopathic Arthritis; Measles; Paediatric; T Cells; Vaccines,; Varicella
Abstract
Measles and chickenpox infections in immunocompromised children cause severe disease and death, and trigger outbreaks in schools and hospitals, putting all children at risk. Approximately 3% of Canadian children are immunocompromised, and this population is expected to grow with increasing use of powerful new medications that effectively treat cancer and autoimmune diseases but also cause profound immune suppression. Children with weakened immune systems may not be sufficiently protected by routine childhood vaccines. Currently, little is known about the factors that affect vaccine-induced antibody levels or how immune cells contribute to protection in this context, resulting in insufficient data to guide clinical practice and infection control measures. In this project, I will evaluate how the measles and chickenpox vaccines protect at-risk children who have weakened immune systems. Using blood samples that have already been collected from children with leukemia, children with arthritis, and healthy controls, I will measure the quantity and quality of antibodies that prevent measles and chickenpox infections. I will also measure how well T cells that target measles and chickenpox reduce the severity of disease and resolve infections, using innovative techniques to acquire in-depth data from low-volume pediatric blood samples. I will compare immune parameters between immunocompromised children and healthy children and use paired samples collected from children before and during treatment to measure changes over time. Next, I will identify characteristics of children who are at greatest risk of not being protected from measles and varicella. Finally, using paired samples collected during and after treatment, I will evaluate the potential for recovery of the immune response. Together, this project will generate recommendations for clinical practice and vaccination policies for at-risk children with weakened immune systems.
Competitiondate
202310
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shapiro, Janna
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~